ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

Eight Scientists Receive $800,000 From Milken

January 12, 1990

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

NIH selects nine scientists for Pioneer Awards.

October 1, 2004

ACS-Roosevelt Fellows Announced

July 29, 1977